scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Chao Ma | |
Anren Kuang | |||
Jiawei Xie | |||
Tiekun Ma | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thyroglobulin | Q20817224 |
P304 | page(s) | 1473-1480 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
P1476 | title | Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning | |
P478 | volume | 46 |
Q36285155 | Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer |
Q43281597 | Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT. |
Q42015291 | Clinical analysis of a patient with a benign lesion of the pharynx misdiagnosed as functional thyroid cancer metastasis |
Q34178115 | Clinical determinants of fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)iodine whole body scans after (131)iodine therapy. |
Q34991946 | Clinical use of PET/CT in thyroid cancer diagnosis and management |
Q36337288 | False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. |
Q36325942 | Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma |
Q37140715 | Influence of the thyroid remnant in the elevation of the serum thyroglobulin after thyroidectomy in differentiated thyroid carcinoma. Importance of the diagnostic iodine total-body scanning |
Q43297979 | Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion |
Q39100644 | Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer |
Q92921005 | Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma |
Q42433641 | Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl's Node |
Q35176280 | Peptide receptor radionuclide therapy of differentiated thyroid cancer: efficacy and toxicity |
Q80341527 | Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation |
Q87345565 | Prospective evaluation of (68)Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative (131)I-whole body scan: comparison with (18)F-FDG PET-CT |
Q35941137 | Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma |
Q24241189 | Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases |
Q81944310 | Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans |
Q57796338 | The role of ultrasound in the follow-up of children with differentiated thyroid cancer |
Q37705061 | Thyroid-Related Protein Expression in the Human Thymus. |
Q44931507 | Thyrotropin variations may explain some positive radioiodine therapy scans in patients with negative diagnostic scans |
Q36177782 | Usefulness of low iodine diet in managing patients with differentiated thyroid cancer - initial results |
Q50901388 | Value of post-therapeutic ¹³¹I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma. |
Search more.